Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:3.2.1.23 (
beta-galactosidase
)
14,648
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The gene for Staphylococcal protein A was fused to the coding sequence of bacterial
beta-galactosidase
, alkaline phosphatase and human
insulin-like growth factor I
(
IGF-I
). The fusion proteins, expressed in bacteria, were purified by affinity chromatography on IgG-Sepharose and antibodies were raised in rabbits. All three fusion proteins elicited specific antibodies against both the inserted protein sequences and the protein A moiety. In the case of
IGF-I
, the protein A moiety in the fusion protein may act as an adjuvant since native
IGF-I
alone is a poor immunogen. The results suggest that the protein A fusion system can be used for efficient antibody production against peptides or proteins expressed from cloned or synthetic genes. To facilitate such gene fusions a set of optimized vectors have been constructed.
...
PMID:Production of specific antibodies against protein A fusion proteins. 309 19
The effects of epidermal growth factor (EGF) and
insulin-like growth factor I
(
IGF-I
) on mature marmoset (Callithrix jacchus) Sertoli cells in vitro were investigated using light and electron microscopic and histochemical means. The morphological data were substantiated by morphometric analysis at the electron microscopic level. In a bicameral chamber system, cultured Sertoli cells displayed a high degree of ultrastructural differentiation and exhibited a polarized appearance. Basally located tight junctions joined adjacent cells. Germ cells of early stages of development were regularly seen. Under the influence of
IGF-I
, cells developed extensive cell-cell contacts. The surface density of smooth endoplasmic reticulum was increased. In contrast, the volume density of lipid inclusions was decreased. The morphological integrity of enclosed germ cells was maintained for a longer period. With EGF, cells were arranged in loose aggregates. Intercellular spaces were widened. The volume density of lipid inclusions was increased. Germ cells exhibited profound signs of degeneration early in culture, paralleled by increased development of phagolysosomes and high acid-
beta-galactosidase
activity. Under the influence of either growth factor, mitochondria displayed a shift from the crista to the tubulo-vesicular type. Mitochondrial dimensions and the volume density of mitochondrial compartment were increased. In comparison with control cultures all documented changes were statistically significant. Our findings indicate that marmoset Sertoli cells are target cells for EGF and
IGF-I
. Moreover, the dynamics of intercellular contacts, germ cell survival, and morphological indices of lipid and/or steroid metabolism seem to be differentially modulated.
...
PMID:Growth factors (EGF, IGF-I) modulate the morphological differentiation of adult marmoset (Callithrix jacchus) Sertoli cells in vitro. 786 Apr 20
Human
insulin-like growth factor I
(
IGF-I
) was expressed in Escherichia coli as a truncated
beta-galactosidase
-
IGF-I
fusion protein. The Lac Z" gene was truncated by removal of a 490 bp fragment which encoded 163 N-terminal residues of
beta-galactosidase
and was connected to the
IGF-I
cDNA by a linker encoding hydroxylamine cleavage recognition sequence. By truncating Lac Z" gene, the overall yield and purification procedures of
IGF-I
from fusion protein have been improved. The fusion protein was produced in the form of insoluble inclusion bodies with isopropyl-1-thio-beta-D-galactoside (IPTG) induction. After cleavage of the fusion protein with hydroxylamine, the released
IGF-I
was purified to homogeneity by a cation exchange chromatography, refolding and reverse-phase high performance liquid chromatography (rp-HPLC). The purified
IGF-I
was found to be indistinguishable from the native
IGF-I
by N-terminal amino acid sequence, SDS-polyacrylamide gel electrophoresis, and rp-HPLC and by biological activities such as thymidine uptake, protein synthesis and receptor binding. These results suggest that the expression and simple purification of recombinant human
IGF-I
described in this paper may be useful for large scale production of
IGF-I
.
...
PMID:High-level expression and simple purification of recombinant human insulin-like growth factor I. 881 76
The effects of mitogens and agents affecting tyrosine phosphorylation signaling on androgen-regulated transcription were investigated. CV-1 and HeLa cells were cotransfected with an androgen receptor (AR) expression vector and an androgen-responsive chloramphenicol acetyltransferase (CAT) reporter gene driven by the mouse mammary tumor virus promoter. Growth factors [epidermal growth factor (EGF) and
insulin-like growth factor I
] that activate receptor tyrosine kinases, an inhibitor of phosphotyrosine phosphatases (vanadate), or an inhibitor of tyrosine kinases (genistein) did not influence basal promoter activity or that of unliganded AR. However, EGF,
insulin-like growth factor I
, and vanadate enhanced AR-dependent transactivation by 1.5- to 2.5-fold, and genistein diminished it by two thirds in the presence of androgen. None of the treatments affected pRSV-CAT or pSV-
beta-galactosidase
expression, suggesting that gross activation of the transcription machinery was not involved. A reporter with two androgen response elements (AREs) in front of the thymidine kinase promoter (p delta ARE2tk-CAT) was used to examine promoter specificity. EGF activated this reporter even in the absence of androgen. However, when EGF was used concomitantly with testosterone, it augmented the action of androgen. Vanadate enhanced androgen-induced transactivation 2-fold without altering basal promoter activity. Neither EGF nor vanadate altered immunoreactive AR content or elicited changes in the receptor's DNA-binding properties. The intracellular content of hormone-binding AR was not influenced by EGF, but was decreased by vanadate and increased by genistein, as judged by [3H]mibolerone binding assays. An AR form lacking the hormone-binding domain (delta 641-902 mutant) transactivated p delta ARE2tk-CAT reporter similar to or better than the wild-type receptor in the presence of androgen. The transactivation by the delta 641-902 mutant was augmented by EGF and vanadate, but was attenuated by genistein, implying that the steroid-binding region is not critical for regulatory events initiated by tyrosine phosphorylation. Collectively, these data indicate that there is cross-talk between androgen-mediated signaling systems and growth factor/receptor tyrosine kinase pathways.
...
PMID:Effects of mitogens on androgen receptor-mediated transactivation. 882 95
Krabbe's disease (globoid cell leukodystrophy) is a progressive cerebral degenerative disease of infancy characterized by severe myelin loss and the presence of globoid bodies in the white matter. Previous studies have suggested that psychosine is the causative agent for the pathogenesis of Krabbe's disease. In the present study, we investigated psychosine-induced injury and cell death of oligodendrocytes in enriched cultures of oligodendrocytes prepared from 3-week-old rat brain. The psychosine concentration sufficient to induce 50% cell death in oligodendrocytes was 30 micrograms/ml in the medium containing serum and 10 micrograms/ml in the serum-free medium. When oligodendrocytes were exposed to psychosine in the presence of phorbol esters, insulin,
insulin-like growth factor I
(
IGF-I
), demethylsulfoxide, or serum albumin, the survival of oligodendrocytes was greatly increased. These results indicate that psychosine cytotoxicity against oligodendrocytes is blocked by phorbol esters, insulin, and
IGF-I
through activation of protein kinase-C, by dimethylsulfoxide through activation of
beta-galactosidase
, and by albumin through its binding to psychosine.
...
PMID:Tissue culture model of Krabbe's disease: psychosine cytotoxicity in rat oligodendrocyte culture. 921 77
Interleukin-1beta is a potent pro-inflammatory cytokine that has been shown to inhibit islet beta cell function as well as to activate Fas-mediated apoptosis in a nitric oxide-dependent manner. Furthermore, this cytokine is effective in recruiting lymphocytes that mediate beta cell destruction in IDDM onset. The
insulin-like growth factor I
(
IGF-I
) has been shown to block IL-1beta actions in vitro. We hypothesized that gene transfer of the
insulin-like growth factor I
to intact human islets could prevent IL-1beta-induced beta cell dysfunction and sensitization to Fas-triggered apoptosis activation. Intact human islets were infected with adenoviral vectors encoding
IGF-I
as well as
beta-galactosidase
and enhanced green fluorescent protein as controls. Adenoviral gene transfer of human
IGF-I
prevented IL-1beta-mediated nitric oxide production from human islets in vitro as well as the suppression of beta cell function as determined by glucose-stimulated insulin production. Moreover,
IGF-I
gene transfer prevented IL-1beta-induced, Fas-mediated apoptosis. These results suggest that locally produced
IGF-I
from cultured islets may be beneficial in maintaining beta cell function and promoting islet survival before and following islet transplantation as a potential therapy for type I diabetes.
...
PMID:Prevention of beta cell dysfunction and apoptosis activation in human islets by adenoviral gene transfer of the insulin-like growth factor I. 1117 13
Histone deacetylases (HDAC) reverse the acetylation of histone and nonhistone proteins and thereby modulate chromatin structure and function of nonhistone proteins. Many tumor cell lines and experimental tumors respond to HDAC inhibition. To assess the role of an individual HDAC isoenzyme in physiology and tumor development, HDAC2-mutant mice were generated from a gene trap embryonic stem cell clone. These mice express a catalytically inactive fusion protein of the NH(2)-terminal part of HDAC2 and
beta-galactosidase
, which fails to integrate into corepressor complexes with mSin3B. They are the first class 1 HDAC mutant mice that are viable although they are approximately 25% smaller than their littermates. Cell number and thickness of intestinal mucosa are reduced. Mutant embryonic fibroblasts fail to respond to
insulin-like growth factor I
(IGF) by the IGF-I-induced increase in cell number observed in wild-type cells. These data suggest a novel link between HDACs and IGF-I-dependent responses. Crossing of HDAC2-mutant with tumor-prone APC(min) mice revealed tumor rates that are lower in HDAC2-deficient mice by 10% to 100% depending on segment of the gut and sex of the mice. These mice provide evidence that the key functions of HDAC2, although not essential for survival of the organism, play a rate-limiting role for tumor development in vivo.
...
PMID:Reduced body size and decreased intestinal tumor rates in HDAC2-mutant mice. 1790 8